Low-dose azacitidine, pioglitazone and all-trans retinoic acid is safe in patients aged ≥60 years with acute myeloid leukemia refractory to standard induction chemotherapy (AMLSG 2...
by Heudobler, Daniel (Author)
, Luke, Florian (Author)
, Hahn, Joachim (Author)
, Grube, Matthias (Author)
, Schlosser, Pavla (Author)
, Kremers, Stephan (Author)
, Sudhoff, Thomas (Author)
, Westermann, Jorg (Author)
, Hutter-Kronke, Marie Luise (Author)
, Schlenk, Richard Friedrich (Author)
, Weber, Daniela (Author)
, Paschka, Peter (Author)
, Zeman, Florian (Author)
, Dohner, Hartmut (Author)
, Herr, Wolfgang (Author)
, Reichle, Albrecht (Author)
, Thomas, Simone (Author)
,
Call Number:
Loading…
Located:
Loading…
Article (Journal)
Editorial
Online Resource